Metabolism and disposition of zamicastat in rats.
disposition, rat
metabolism
pharmacokinetics
zamicastat
Journal
Xenobiotica; the fate of foreign compounds in biological systems
ISSN: 1366-5928
Titre abrégé: Xenobiotica
Pays: England
ID NLM: 1306665
Informations de publication
Date de publication:
02 Oct 2024
02 Oct 2024
Historique:
medline:
3
10
2024
pubmed:
3
10
2024
entrez:
3
10
2024
Statut:
aheadofprint
Résumé
The metabolism and disposition of zamicastat, a reversible dopamine β-hydroxylase (DβH) inhibitor, developed for treatment of Pulmonary Arterial Hypertension (PAH), were investigated in rats after oral and intravenous administration of [
Identifiants
pubmed: 39359020
doi: 10.1080/00498254.2024.2411993
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM